Technetium (99mTc) sulesomab is a radiolabeled monoclonal antibody (MAb) used for imaging tumors in the body. It is composed of a mouse IgG1κ antibody which has been radiolabeled with technetium-99m, a radioisotope with a short physical half-life of approximately 6 hours. The antibody binds specifically to the tumor-associated antigen (TAA) present on the surface of certain types of tumor cells. This allows it to accumulate in tumors, allowing them to be detected on imaging scans. Technetium (99mTc) sulesomab is used primarily to detect and monitor the progress of metastatic breast cancer and colorectal cancer. It can also be used to detect and monitor other types of cancer, including ovarian, gastric, and non-small cell lung cancer.
Technetium (99mTc) sulesomab, also known by the trade name LeukoScan, is a radiopharmaceutical used in nuclear medicine for imaging purposes. Here's a breakdown of its key components and functions:
Components:
- Technetium-99m (⁹⁹mTc): This is the radioactive component, a human-made isotope of technetium. It emits gamma rays during decay, which are crucial for creating images.
- Sulesomab: This is a fragment of a monoclonal antibody, specifically a Fab fragment. It binds to a specific protein (NCA-90) on the surface of white blood cells called granulocytes.
Medical Use:
Technetium (99mTc) sulesomab is primarily used for imaging:
- Inflammation: By targeting granulocytes, which are immune cells that accumulate in areas of inflammation, Tc-99m sulesomab helps visualize inflamed tissues. This can be helpful in diagnosing infections in bones, joints, or soft tissues.
Mechanism of Action:
- Injection and Targeting: Tc-99m sulesomab is injected into a vein and travels through the bloodstream.
- Granulocyte Binding: The sulesomab fragment in the agent specifically binds to the NCA-90 antigen on granulocytes.
- Inflammation Accumulation: Since granulocytes tend to accumulate in inflamed areas, Tc-99m sulesomab concentrates in those regions as well.
- Gamma Ray Detection: The gamma rays emitted by decaying Tc-99m are detectable by a gamma camera. This allows for the creation of images that show the distribution of Tc-99m sulesomab in the body, highlighting areas with higher concentrations of granulocytes, which often indicates inflammation.